DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nitecapone
Nitecapone
(12) United States Patent (10) Patent No.: US 7,786,126 B2 Mccreary Et Al
Download Product Insert (PDF)
Case 2:10-Cv-05078-CCC-MF Document 540 Filed 09/20/13 Page 1 of 59 Pageid: 14610
Pharmaceutical Appendix to the Tariff Schedule 2
Development of Purification Strategies for SCOMT and MBCOMT Proteins by Affinity Chromatography
Lyophilization and a Preliminary Thermodynamic Characterization of Recombinant SCOMT His6
Catechol-O-Methyltransferase Inhibitor, on the Motor Response to Acute Treatment with Levodopa in Patients with Parkinson's Disease
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(Boosters)—Escort for Drugs Against Degrading Enzymes and Beyond
Stembook 2018.Pdf
(Boosters)—Escort for Drugs Against Degrading Enzymes and Beyond
Development of a PC12 Cell-Based Assay for in Vitro Screening of Catechol-O- Methyltransferase Inhibitors
Chem. Pharm. Bull. 68(5): 447-451 (2020)
Oxidative Stress and Cerebral Endothelial Cells: Regulation of the Blood–Brain-Barrier and Antioxidant Based Interventions☆
Catechol-O-Methyltransferase Inhibitor, on the Motor Response to Acute Treatment with Levodopa in Patients with Parkinson's Disease
WO 2014/001973 Al 3 January 2014 (03.01.2014) P O P C T
L-Dopa) in Living Brain
Marrakesh Agreement Establishing the World Trade Organization
Top View
The Synthesis and Evaluation of Dual Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase
2021 Winter Caregiver's Companion
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Graphical Analysis of 6-Fluoro-L-Dopa Trapping: Effect of Inhibition of Catechol-O-Methyltransferase
5-Drugs Used in Parkinsonism
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Docking Based De Novo Design of Few Tolcapone Derivatives As Catechol-O- Methyl Transferase (Comt) Inhibitors
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Bioactive Compound Library Plus (96-Well)
Wo 2007/044693 A2
3288 Oxidative Stress in Neurodegeneration and Available
Identification of Antiparkinsonian Drugs in the 6-Hydroxydopamine Zebrafish Model 2 Rita L
Transport Across the Blood-Brain Barrier
Conformationally Restricted Tn Antigen Mimics: Synthesis, Structural Analysis and Biological Properties
WO 2010/024870 Al
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
Neurogenesis Via Modulation of the Muscarinic Receptors
(10) Patent No.: US 8772346 B2
Dopamine-Induced Recruitment of Dopamine D1 Receptors to the Plasma Membrane
Winter 2021 Issue
(12) Patent Application Publication (10) Pub. No.: US 2016/0022573 A1 Yacoby-Zeevi (43) Pub
US 2013/0017274 A1 No Lithium + Pavis Lithium + Paib No Liti
Evolution of Sedation in Dental Practice: from the Ridiculous to the Sublime
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2006) (Rev
1111111111111111111Imnumu
N-Glucuronidation of Drugs and Other Xenobiotics
Official Journal ISSN 0378-6978 L97 of the European Communities Volume 45
WO 2011/012715 Al
Learningpharmacology 2018.Pdf
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Molecular Mechanisms of Neurodegenerative Diseases
COMT Inhibitors in Parkinson's Disease